Follistatin.

Follistatin is a endogenous glycoprotein, activin-binding protein, and myostatin inhibitor. With the molecular formula Glycoprotein and a molecular weight of ~34 kDa (CAS: 117628-82-7), it is characte...

$156.00

Lab Verified

Clinical Grade

PMID Cited

Mechanism of Action.

Published preclinical research has characterized the following molecular pathways and receptor interactions for Follistatin.

Receptor interaction

Myostatin (GDF-8)

Published research demonstrates Follistatin modulates targeted signaling cascades within cell tissue models.

Signaling cascade

Activin A

In cellular environments, Follistatin exhibits selective binding and corresponding pathway activation.

Evidence Based

Clinical Literature

View All Studies

Preclinical

Research review on Follistatin molecular characterization.

Preclinical studies have characterized the molecular properties and receptor binding profiles of Follistatin in standardized assay systems.

Preclinical

Follistatin structure-activity relationship analysis.

Structure-activity relationship studies have examined the functional domains and binding characteristics of Follistatin in cell-free and cell-based systems.

RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.

Continue Exploring